4,192
Views
39
CrossRef citations to date
0
Altmetric
Research Article

The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery

, , , &
Pages 1486-1491 | Received 02 Apr 2014, Accepted 15 Jul 2014, Published online: 26 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Mohamed Adly, Mohamed Shalaby, Mohamed H Zedan & Walaa Y Elsabeeny. (2022) Evaluating intraoperative norepinephrine versus fresh frozen plasma in patients undergoing cytoreductive surgery and HIPEC to reduce renal insult. Egyptian Journal of Anaesthesia 38:1, pages 483-490.
Read now
Chao-Yu Chen, Hung-Yu Chang, Chang-Hsien Lu, Min-Chi Chen, Tzu-Hao Huang, Li-Wen Lee, Yu-San Liao, Vincent Chin-Hung Chen, Wen-Shih Huang, Yu-Che Ou, Feng-Chi Lung & Ting-Yao Wang. (2020) Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. International Journal of Hyperthermia 37:1, pages 1279-1286.
Read now
N. Laplace, V. Kepenekian, A. Friggeri, O. Vassal, F. Ranchon, C. Rioufol, W. Gertych, L. Villeneuve, O. Glehen & N. Bakrin. (2020) Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin. International Journal of Hyperthermia 37:1, pages 897-902.
Read now
Ravish Kapoor, Kristen Ashlee Robinson, Juan Pablo Cata, Pascal Owusu-Agyemang, Jose Miguel Soliz, Michael Hernandez, Paul Mansfield & Brian Badgwell. (2019) Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy. International Journal of Hyperthermia 36:1, pages 492-497.
Read now
Juan P. Cata, Acsa M. Zavala, Antoinette Van Meter, Uduak U. Williams, Jose Soliz, Mike Hernandez & Pascal Owusu-Agyemang. (2018) Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. International Journal of Hyperthermia 34:5, pages 538-544.
Read now
Grace Hwei Ching Tan, Nicholas Brian Shannon, Claramae Shulyn Chia, Khee Chee Soo & Melissa Ching Ching Teo. (2018) Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). International Journal of Hyperthermia 34:5, pages 595-600.
Read now
Nina Ashraf-Kashani & John Bell. (2017) Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei. International Journal of Hyperthermia 33:6, pages 675-678.
Read now

Articles from other publishers (31)

Arthur Samoylovich, Bronwyn Jennings, Catherine Shannon, Jermaine I. Coward, Rohan Lourie, John Riordan, Nai An Lai, Willemien J. van Driel, Nimithri Cabraal, Nisha Jagasia, Naven Chetty, Sanjeev Naidu, Lewis C. Perrin & Sinead C. Barry. (2023) Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high‐grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context. Australian and New Zealand Journal of Obstetrics and Gynaecology 63:5, pages 702-708.
Crossref
S. V. S. Deo, M. D. Ray, Lalit Kumar, Sachin Khuranna, Raja Pramanik, Ashutosh Mishra, Babul Bansal, Premanand N, Sushma Bhatnagar, Rakesh Garg & Vinod Kumar. (2023) Pattern of Care in Real-World Scenario on Advanced Epithelial Ovarian Cancer in a Tertiary Referral Oncology Centre in India — ISPSM Collaborative Study. Indian Journal of Surgical Oncology 14:S1, pages 233-239.
Crossref
Lukas F. Liesenfeld & Andreas Brandl. (2023) Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion. Langenbeck's Archives of Surgery 408:1.
Crossref
Lukas F. Liesenfeld, Eva Quiring, Mohammed Al-Saeedi, Christian Nusshag, Markus W. Büchler & Martin Schneider. (2022) Extensive Peritonectomy is an Independent Risk Factor for Cisplatin HIPEC-Induced Acute Kidney Injury. Annals of Surgical Oncology 30:5, pages 2646-2656.
Crossref
Changchun Jian, Hai Mou, Ye Zhang, Qingxin Fan & Yunsheng Ou. (2023) Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Christopher W. Tam, Shreyajit R. Kumar & Jarva Chow. (2023) Acute Kidney Injury and Renal Replacement Therapy. Anesthesiology Clinics 41:1, pages 211-230.
Crossref
Yun Bai, Ye Du, Pengpeng Ye & Yang Luo. (2023) Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer. Frontiers in Oncology 13.
Crossref
Anais Alonso, Winston Liauw, Helen Kennedy, Nayef A. Alzahrani & David L. Morris. (2022) Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae. Pleura and Peritoneum 7:2, pages 87-93.
Crossref
Toshiyuki KITAI, Kazuyuki OKADA, Hidekazu TAKAGI & Naoki UYAMA. (2022) Risk Factors of Causing Acute Kidney Injury after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Cisplatin腹膜切除とCDDPを用いた腹腔内温熱化学療法後の急性腎障害の危険因子. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 83:7, pages 1216-1220.
Crossref
Annika Kurreck, Felix Gronau, Miguel Enrique Alberto Vilchez, Wiltrud Abels, Philipp Enghard, Andreas Brandl, Roland Francis, Bettina Föhre, Christian Lojewski, Johann Pratschke, Peter Thuss-Patience, Dominik Modest, Beate Rau & Linda Feldbrügge. (2021) Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study. Annals of Surgical Oncology 29:1, pages 152-162.
Crossref
Lukas F. Liesenfeld, Benedikt Wagner, H. Christian Hillebrecht, Maik Brune, Christoph Eckert, Johannes Klose, Thomas Schmidt, Markus W. Büchler & Martin Schneider. (2021) HIPEC-Induced Acute Kidney Injury: A Retrospective Clinical Study and Preclinical Model. Annals of Surgical Oncology 29:1, pages 139-151.
Crossref
S. V. S. Deo, Babul Bansal & Jyoutishman Saikia. 2022. Onco-critical Care. Onco-critical Care 491 505 .
Álvaro Jesús Gómez-Ruiz, Alida González-Gil, José Gil, Felipe Alconchel, Álvaro Navarro-Barrios, Elena Gil-Gómez, Jerónimo Martínez, Aníbal Nieto, Carlos García-Palenciano & Pedro Antonio Cascales-Campos. (2021) Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used. Langenbeck's Archives of Surgery 406:7, pages 2449-2456.
Crossref
Bradley White, Fadi Dahdaleh, Samer A. Naffouje, Neerav Kothari, Jessica Berg, Wendy Wiemann & George I. Salti. (2021) Impact of Enhanced Recovery After Surgery on Postoperative Outcomes for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology 28:9, pages 5265-5272.
Crossref
Matilde Zaballos, Mercedes Power, María Iluminada Canal-Alonso, María Ángeles González-Nicolás, Wenceslao Vasquez-Jimenez, Pablo Lozano-Lominchar, Pilar Cabrerizo-Torrente, Natividad Palencia-García, Susana Gago-Quiroga, María Dolores Ginel-Feito, Consuelo Jiménez, Alberto Lázaro & Luis González-Bayón. (2021) Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy. International Journal of Molecular Sciences 22:3, pages 1239.
Crossref
Andrew M. Blakely & Byrne Lee. 2020. Cancer Regional Therapy. Cancer Regional Therapy 179 188 .
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao, Min Yan & Zheng-Gang Zhu. (2019) Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer 19:1.
Crossref
Hakeam Hakeam, Azzam Ayman, Al Taweel Waleed & Tarek Amen. (2019) Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Pleura and Peritoneum 4:4.
Crossref
N. Esteve-Pérez, A. Ferrer-Robles, G. Gómez-Romero, D. Fabián-Gonzalez, M. Verd-Rodriguez, L. C. Mora-Fernandez, J. J. Segura-Sampedro, S. Tejada-Gavela & R. Morales-Soriano. (2018) Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study. Clinical and Translational Oncology 21:4, pages 451-458.
Crossref
Martina Aida Angeles, François Quenet, Pierre Vieille, Laurence Gladieff, Jean Ruiz, Muriel Picard, Federico Migliorelli, Leonor Chaltiel, Carlos Martínez-Gómez, Alejandra Martinez & Gwénaël Ferron. (2019) Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis. International Journal of Gynecologic Cancer 29:2, pages 382-391.
Crossref
SohanLal Solanki, Sudipta Mukherjee, Vandana Agarwal, RaghuS Thota, Kalpana Balakrishnan, ShagunBhatia Shah, Neha Desai, Rakesh Garg, ReshmaP Ambulkar, NitinMadhukar Bhorkar, Viplab Patro, Snita Sinukumar, MeenakshiV Venketeswaran, MaliniP Joshi, RajeshHolalu Chikkalingegowda, Vijaya Gottumukkala, Pascal Owusu-Agyemang, AvanishP Saklani, SanketSharad Mehta, RamakrishnanAyloor Seshadri, JohnC Bell, Sushma Bhatnagar & JigeeshuV Divatia. (2019) Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian Journal of Anaesthesia 63:12, pages 972.
Crossref
Yong Jae Lee, Jung-Yun Lee, Min-Soo ChoEun Ji Nam, Sang Wun Kim, Sunghoon Kim & Young Tae Kim. (2019) Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study. Journal of Gynecologic Oncology 30:1.
Crossref
Samer A. Naffouje, Kiara A. Tulla, Regina Chorley, Nancy Armstrong & George I. Salti. (2018) Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Annals of Medicine and Surgery 35, pages 163-168.
Crossref
. (2018) Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. New England Journal of Medicine 378:14, pages 1362-1364.
Crossref
K. Van der Speeten & L. Lemoine. 2018. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond 79 102 .
Kurt Van der Speeten, Lieselotte Lemoine & Paul Sugarbaker. (2017) Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura and Peritoneum 2:2, pages 63-72.
Crossref
C. Raspé, L. Flöther, R. Schneider, M. Bucher & P. Piso. (2017) Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. European Journal of Surgical Oncology (EJSO) 43:6, pages 1013-1027.
Crossref
A. Arjona-S?nchez, A. Cadenas-Febres, J. Cabrera-Bermon, F.C. Mu?oz-Casares, A. Casado-Adam, J.M. S?nchez-Hidalgo, M. L?pez-Andreu, J. Brice?o-Delgado & S. Rufi?n-Pe?a. (2016) ?Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances?. European Journal of Surgical Oncology (EJSO) 42:6, pages 869-876.
Crossref
Sanket S. Mehta, Maxilliano Gelli, Deepesh Agarwal & Diane Go?r?. (2016) Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian Journal of Surgical Oncology 7:2, pages 225-229.
Crossref
. (2015) Cisplatin. Reactions Weekly 1550:1, pages 60-60.
Crossref
JalajaKoppa Ramegowda, MohammedAbdul Salam, Vasant Nayak & Shabber Zaveri. (2015) Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure. Indian Journal of Anaesthesia 59:12, pages 807.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.